Pharmaceutical Technology-03-02-2004

March 02, 2004

Healthcare coverage and costs remain prime concerns for FDA as the number of uninsured Americans continues to grow.

March 02, 2004

Selecting a buffer for the formulation of a protein requires an understanding of the potential effects of various buffers on protein stabilization.

March 02, 2004

Protecting a product from temperature abuse is gaining importance as regulators seek proof of product stability throughout the distribution process.

March 02, 2004

Erythrocytes, the most abundant cells in the human body, have potential carrier capabilities for the delivery of drugs.

March 02, 2004

The need to provide both operator and product protection while developing more efficient containment strategies has initiated a wave of innovative solutions in barrier/isolation equipment design and implementation.

March 02, 2004

Companies that leverage new collaborative technologies in the manufacture, packaging, and distribution of clinical trial materials will be best positioned to reduce their time to market.

March 02, 2004

Pharmaceutical science and technology news

March 02, 2004

As outsourcing services become a more integral part of pharmaceutical processes, drug companies are taking a harder line on consequential.